These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35705919)

  • 1. Hydroxychloroquine induces apoptosis of myeloid-derived suppressor cells via up-regulation of CD81 contributing to alleviate lupus symptoms.
    Ni J; Zhu H; Lu L; Zhao Z; Jiang J; You X; Wang Y; Ma Y; Yang Z; Hou Y; Dou H
    Mol Med; 2022 Jun; 28(1):65. PubMed ID: 35705919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxychloroquine Inhibits the Differentiation of Th17 Cells in Systemic Lupus Erythematosus.
    Yang J; Yang X; Yang J; Li M
    J Rheumatol; 2018 Jun; 45(6):818-826. PubMed ID: 29545450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-type lectin receptor Dectin3 deficiency balances the accumulation and function of FoxO1-mediated LOX-1
    Li D; Lu L; Kong W; Xia X; Pan Y; Li J; Wang J; Wang T; Liang J; Dou H; Hou Y
    Cell Death Dis; 2021 Sep; 12(9):829. PubMed ID: 34480018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid-derived suppressor cells contribute to systemic lupus erythaematosus by regulating differentiation of Th17 cells and Tregs.
    Ji J; Xu J; Zhao S; Liu F; Qi J; Song Y; Ren J; Wang T; Dou H; Hou Y
    Clin Sci (Lond); 2016 Aug; 130(16):1453-67. PubMed ID: 27231253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of dihydroartemisinin in inhibiting senescence of myeloid-derived suppressor cells from lupus mice via Nrf2/HO-1 pathway.
    Li D; Qi J; Wang J; Pan Y; Li J; Xia X; Dou H; Hou Y
    Free Radic Biol Med; 2019 Nov; 143():260-274. PubMed ID: 31419476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Halofuginone ameliorates systemic lupus erythematosus by targeting Blk in myeloid-derived suppressor cells.
    Ni J; Li X; Tu X; Zhu H; Wang S; Hou Y; Dou H
    Int Immunopharmacol; 2023 Jan; 114():109487. PubMed ID: 36493694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch1 signalling controls the differentiation and function of myeloid-derived suppressor cells in systemic lupus erythematosus.
    Li X; Fei F; Yao G; Yang X; Geng L; Wang D; Gao Y; Hou Y; Sun L
    Immunology; 2023 Jan; 168(1):170-183. PubMed ID: 36038992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus.
    Dong G; Yang Y; Li X; Yao X; Zhu Y; Zhang H; Wang H; Ma Q; Zhang J; Shi H; Ning Z; Yan F; Zhai W; Dai J; Li Z; Li C; Ming J; Xue Q; Meng X; Si C; Xiong H
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165554. PubMed ID: 31513833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cell transplantation alleviated atherosclerosis in systemic lupus erythematosus through reducing MDSCs.
    Yao G; Qi J; Li X; Tang X; Li W; Chen W; Xia N; Wang S; Sun L
    Stem Cell Res Ther; 2022 Jul; 13(1):328. PubMed ID: 35850768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine in systemic lupus erythematosus (SLE).
    Ponticelli C; Moroni G
    Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroquine Autophagic Inhibition Rebalances Th17/Treg-Mediated Immunity and Ameliorates Systemic Lupus Erythematosus.
    An N; Chen Y; Wang C; Yang C; Wu ZH; Xue J; Ye L; Wang S; Liu HF; Pan Q
    Cell Physiol Biochem; 2017; 44(1):412-422. PubMed ID: 29141242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuation Rate, Safety and Efficacy of Hydroxychloroquine Treatment in a Retrospective Cohort of Systemic Lupus Erythematosus in a Japanese Municipal Hospital.
    Hosokawa Y; Oiwa H
    Intern Med; 2020 Oct; 59(20):2485-2490. PubMed ID: 32641656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multi-targets mechanism of hydroxychloroquine in the treatment of systemic lupus erythematosus based on network pharmacology.
    Xie B; Geng Q; Xu J; Lu H; Luo H; Hu Y; Song X
    Lupus; 2020 Nov; 29(13):1704-1711. PubMed ID: 32854577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: A possible mechanism for the reversal of atherosclerosis in the disease.
    Lang MG; Vinagre CG; Bonfa E; Freitas FR; Pasoto SG; Brito TS; Seguro LP; Maranhão RC; Borba EF
    Lupus; 2022 May; 31(6):659-665. PubMed ID: 35332823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis in peripheral blood lymphocytes following treatment in vitro with hydroxychloroquine.
    Meng XW; Feller JM; Ziegler JB; Pittman SM; Ireland CM
    Arthritis Rheum; 1997 May; 40(5):927-35. PubMed ID: 9153556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baicalein ameliorates pristane-induced lupus nephritis via activating Nrf2/HO-1 in myeloid-derived suppressor cells.
    Li D; Shi G; Wang J; Zhang D; Pan Y; Dou H; Hou Y
    Arthritis Res Ther; 2019 Apr; 21(1):105. PubMed ID: 31023362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Sacre K; Criswell LA; McCune JM
    Arthritis Res Ther; 2012 Jun; 14(3):R155. PubMed ID: 22734582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between hydroxychloroquine levels and disease activity in a predominantly Hispanic systemic lupus erythematosus cohort.
    Geraldino-Pardilla L; Perel-Winkler A; Miceli J; Neville K; Danias G; Nguyen S; Dervieux T; Kapoor T; Giles J; Askanase A
    Lupus; 2019 Jun; 28(7):862-867. PubMed ID: 31122136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed Death-Ligand 1 Expression Potentiates the Immune Modulatory Function Of Myeloid-Derived Suppressor Cells in Systemic Lupus Erythematosus.
    Park MJ; Baek JA; Choi JW; Jang SG; Kim DS; Park SH; Cho ML; Kwok SK
    Front Immunol; 2021; 12():606024. PubMed ID: 33986739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Hydroxychloroquine Therapy for Systemic Lupus Erythematosus Patients Depend on Administration Dose.
    Wakiya R; Kameda T; Nakashima S; Shimada H; Fahmy Mansour MM; Kato M; Miyagi T; Kadowaki N; Dobashi H
    Intern Med; 2020 Sep; 59(17):2105-2112. PubMed ID: 32522920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.